rs181092713

Variant summary

Our verdict is Benign. The variant received -11 ACMG points: 2P and 13B. PM1BP4_StrongBP6BS1BS2

The NM_001393500.2(TOMT):​c.253G>A​(p.Val85Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000722 in 1,491,510 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0037 ( 4 hom., cov: 32)
Exomes 𝑓: 0.00038 ( 2 hom. )

Consequence

TOMT
NM_001393500.2 missense

Scores

18

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:3

Conservation

PhyloP100: 1.06

Publications

2 publications found
Variant links:
Genes affected
TOMT (HGNC:55527): (transmembrane O-methyltransferase) This gene encodes a catechol-O-methyltransferase that catalyzes the transfer of a methyl group from S-adenosyl-L-methionine to a hydroxyl group of catechols and is essential for auditory and vestibular function. Mutations in this gene have been associated with nonsyndromic deafness. Readthrough transcription is observed across this gene and the adjacent leucine-rich repeat containing 51 gene. A third locus (GeneID:220074) is defined to represent the readthrough transcripts. [provided by RefSeq, Feb 2021]
LRTOMT (HGNC:25033): (leucine rich transmembrane and O-methyltransferase domain containing) This locus represents naturally occurring readthrough transcription between the neighboring LRRC51 (leucine-rich repeat containing 51) and TOMT (transmembrane O-methyltransferase) genes on chromosome 11. The readthrough transcript encodes a fusion protein that shares sequence identity with each individual gene product. Multiple reports implicate mutations in this gene in nonsyndromic deafness.[provided by RefSeq, Feb 2021]
ANAPC15 (HGNC:24531): (anaphase promoting complex subunit 15) Involved in regulation of mitotic cell cycle spindle assembly checkpoint. Part of anaphase-promoting complex. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -11 ACMG points.

PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 4 uncertain in NM_001393500.2
BP4
Computational evidence support a benign effect (MetaRNN=0.0081934035).
BP6
Variant 11-72106204-G-A is Benign according to our data. Variant chr11-72106204-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 44039.We mark this variant Likely_benign, oryginal submission is: [Conflicting_classifications_of_pathogenicity].
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00375 (571/152342) while in subpopulation AFR AF = 0.0133 (552/41574). AF 95% confidence interval is 0.0124. There are 4 homozygotes in GnomAd4. There are 285 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 4 gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TOMTNM_001393500.2 linkc.253G>A p.Val85Ile missense_variant Exon 1 of 3 ENST00000541899.3 NP_001380429.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TOMTENST00000541899.3 linkc.253G>A p.Val85Ile missense_variant Exon 1 of 3 5 NM_001393500.2 ENSP00000494667.1 A0A2R8Y5M8
LRTOMTENST00000307198.11 linkc.352G>A p.Val118Ile missense_variant Exon 5 of 7 2 ENSP00000305742.7

Frequencies

GnomAD3 genomes
AF:
0.00374
AC:
570
AN:
152224
Hom.:
4
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0133
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000916
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00191
GnomAD2 exomes
AF:
0.00104
AC:
124
AN:
118756
AF XY:
0.000785
show subpopulations
Gnomad AFR exome
AF:
0.0151
Gnomad AMR exome
AF:
0.000423
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000212
Gnomad OTH exome
AF:
0.000285
GnomAD4 exome
AF:
0.000378
AC:
506
AN:
1339168
Hom.:
2
Cov.:
30
AF XY:
0.000338
AC XY:
221
AN XY:
653256
show subpopulations
African (AFR)
AF:
0.0147
AC:
450
AN:
30648
American (AMR)
AF:
0.000430
AC:
14
AN:
32582
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
22684
East Asian (EAS)
AF:
0.00
AC:
0
AN:
34948
South Asian (SAS)
AF:
0.00
AC:
0
AN:
74138
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
35248
Middle Eastern (MID)
AF:
0.000182
AC:
1
AN:
5480
European-Non Finnish (NFE)
AF:
0.00000286
AC:
3
AN:
1047744
Other (OTH)
AF:
0.000682
AC:
38
AN:
55696
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
27
54
82
109
136
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00375
AC:
571
AN:
152342
Hom.:
4
Cov.:
32
AF XY:
0.00383
AC XY:
285
AN XY:
74498
show subpopulations
African (AFR)
AF:
0.0133
AC:
552
AN:
41574
American (AMR)
AF:
0.000915
AC:
14
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68042
Other (OTH)
AF:
0.00189
AC:
4
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
30
60
89
119
149
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00560
Hom.:
0
Bravo
AF:
0.00422
ESP6500AA
AF:
0.0152
AC:
21
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00140
AC:
35
Asia WGS
AF:
0.000866
AC:
3
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:2
Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 25, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autosomal recessive nonsyndromic hearing loss 63 Uncertain:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -

not specified Benign:1
Mar 13, 2013
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Val118Ile in Exon 05 of LRTOMT: This variant is not expected to have clinical si gnificance because it has been identified in 1.5% (21/1384) of African American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http: //evs.gs.washington.edu/EVS). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.092
BayesDel_addAF
Benign
-0.60
T
BayesDel_noAF
Benign
-0.63
CADD
Benign
16
DANN
Benign
0.97
DEOGEN2
Benign
0.10
T;T;.
Eigen
Benign
-0.50
Eigen_PC
Benign
-0.38
FATHMM_MKL
Benign
0.45
N
LIST_S2
Benign
0.68
T;.;T
MetaRNN
Benign
0.0082
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.83
L;L;.
PhyloP100
1.1
PrimateAI
Benign
0.27
T
PROVEAN
Benign
-0.74
N;N;.
REVEL
Benign
0.028
Sift
Benign
0.24
T;T;.
Sift4G
Benign
0.23
T;T;.
Polyphen
0.0
B;B;.
Vest4
0.094
MVP
0.11
MPC
0.054
ClinPred
0.017
T
GERP RS
1.4
PromoterAI
0.025
Neutral
Varity_R
0.12
gMVP
0.17
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs181092713; hg19: chr11-71817250; COSMIC: COSV109415860; COSMIC: COSV109415860; API